EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 32 (2025) Parasite, 32 (2025) 17 References
Open Access
Issue
Parasite
Volume 32, 2025
Article Number 17
Number of page(s) 10
DOI https://doi.org/10.1051/parasite/2025011
Published online 05 March 2025
  1. Ahlawat S, Asha, Sharma KK. 2021. Gut-organ axis: a microbial outreach and networking. Letters on Applied Microbiology, 72(6), 636–668. [CrossRef] [PubMed] [Google Scholar]
  2. Albhaisi SAM, Bajaj JS, Sanyal AJ. 2020. Role of gut microbiota in liver disease. American Journal of Physiology – Gastrointestinal and Liver Physiology, 318(1), G84–G98. [CrossRef] [PubMed] [Google Scholar]
  3. Banerjee S, van der Heijden MGA. 2023. Soil microbiomes and one health. Nature Reviews Microbiology, 21(1), 6–20. [Google Scholar]
  4. Berger G, Wunderink RG. 2013. Lung microbiota: genuine or artifact? Israel Medical Association Journal, 15(12), 731–733. [Google Scholar]
  5. Brandl K, Kumar V, Eckmann L. 2017. Gut-liver axis at the frontier of host-microbial interactions. American Journal of Physiology – Gastrointestinal and Liver Physiology, 312(5), G413–G419. [CrossRef] [PubMed] [Google Scholar]
  6. Chen C, Li L, Wu Z, Chen H, Fu S. 2007. Effects of lactitol on intestinal microflora and plasma endotoxin in patients with chronic viral hepatitis. Journal of Infection, 54(1), 98–102. [CrossRef] [Google Scholar]
  7. Dang AT, Marsland BJ. 2019. Microbes, metabolites, and the gut-lung axis. Mucosal Immunology, 12(4), 843–850. [CrossRef] [PubMed] [Google Scholar]
  8. Dickson RP, Huffnagle GB. 2015. The lung microbiome: New principles for respiratory bacteriology in health and disease. PLoS Pathogens, 11(7), e1004923. [CrossRef] [PubMed] [Google Scholar]
  9. Gakosso LGC, Baadi F, Abakka FZ, Basraoui D, Jalal H. 2020. The visceral larva migrans caused by Toxocara canis: a case report. Pan African Medical Journal, 36, 150. [Google Scholar]
  10. Iannacone M, Guidotti LG. 2022. Immunobiology and pathogenesis of hepatitis B virus infection. Nature Reviews Immunology, 22(1), 19–32. [CrossRef] [PubMed] [Google Scholar]
  11. Iwauchi M, Horigome A, Ishikawa K, Mikuni A, Nakano M, Xiao JZ, Odamaki T, Hironaka S. 2019. Relationship between oral and gut microbiota in elderly people. Immunity Inflammation and Disease, 7(3), 229–236. [CrossRef] [PubMed] [Google Scholar]
  12. Lindsey JO, Pierce AK. 1978. An examination of the microbiologic flora of normal lung of the dog. American Review of Respiratory Disease, 117(3), 501–505. [Google Scholar]
  13. Ma PJ, Wang MM, Wang Y. 2022. Gut microbiota: A new insight into lung diseases. Biomedicine & Pharmacotherapy, 155, 113810. [CrossRef] [Google Scholar]
  14. Magruder M, Sholi AN, Gong C, Zhang L, Edusei E, Huang J, Albakry S, Satlin MJ, Westblade LF, Crawford C, Dadhania DM, Lubetzky M, Taur Y, Littman E, Ling L, Burnham P, De Vlaminck I, Pamer E, Suthanthiran M, Lee JR. 2019. Gut uropathogen abundance is a risk factor for development of bacteriuria and urinary tract infection. Nature Communications, 10(1), 5521. [CrossRef] [PubMed] [Google Scholar]
  15. Neut C, Bulois P, Desreumaux P, Membré JM, Lederman E, Gambiez L, Cortot A, Quandalle P, van Kruiningen H, Colombel JF. 2002. Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn’s disease. American Journal of Gastroenterology, 97(4), 939–946. [CrossRef] [PubMed] [Google Scholar]
  16. Niza MM, Ferreira AJ, Peleteiro MC, Vilela CL. 2004. Bacteriological study of the liver in dogs. Journal of Small Animal Practice, 45(8), 401–404. [CrossRef] [PubMed] [Google Scholar]
  17. Ohkusa T, Sato N, Ogihara T, Morita K, Ogawa M, Okayasu I. 2002. Fusobacterium varium localized in the colonic mucosa of patients with ulcerative colitis stimulates species-specific antibody. Journal of Gastroenterology and Hepatology, 17(8), 849–853. [CrossRef] [PubMed] [Google Scholar]
  18. Pabst O, Hornef MW, Schaap FG, Cerovic V, Clavel T, Bruns T. 2023. Gut-liver axis: barriers and functional circuits. Nature Reviews Gastroenterology & Hepatology, 20(7), 447–461. [CrossRef] [PubMed] [Google Scholar]
  19. Qin N, Yang F, Li A, Prifti E, Chen Y, Shao L, Guo J, Le Chatelier E, Yao J, Wu L, Zhou J, Ni S, Liu L, Pons N, Batto JM, Kennedy SP, Leonard P, Yuan C, Ding W, Chen Y, Hu X, Zheng B, Qian G, Xu W, Ehrlich SD, Zheng S, Li L. 2014. Alterations of the human gut microbiome in liver cirrhosis. Nature, 513(7516), 59–64. [CrossRef] [PubMed] [Google Scholar]
  20. Rodríguez-Caballero A, Martínez-Gordillo MN, Medina-Flores Y, Medina-Escutia ME, Meza-Lucas A, Correa D, Caballero-Salazar S, Ponce-Macotela M. 2015. Successful capture of Toxocara canis larva antigens from human serum samples. Parasites & Vectors, 8, 264. [CrossRef] [PubMed] [Google Scholar]
  21. Sieng S, Chen P, Wang N, Xu JY, Han Q. 2023. Toxocara canis-induced changes in host intestinal microbial communities. Parasites & Vectors, 16(1), 462. [CrossRef] [PubMed] [Google Scholar]
  22. Singh H, Torralba MG, Moncera KJ, DiLello L, Petrini J, Nelson KE, Pieper R. 2019. Gastro-intestinal and oral microbiome signatures associated with healthy aging. GeroScience, 41(6), 907–921. [CrossRef] [PubMed] [Google Scholar]
  23. Stoma I, Littmann ER, Peled JU, Giralt S, van den Brink MRM, Pamer EG, Taur Y. 2021. Compositional flux within the intestinal microbiota and risk for bloodstream infection with Gram-negative bacteria. Clinical Infectious Diseases, 73(11), e4627–e4635. [CrossRef] [PubMed] [Google Scholar]
  24. Taira K, Permin A, Kapel CM. 2003. Establishment and migration pattern of Toxocara canis larvae in chickens. Parasitology Research, 90(6), 521–523. [CrossRef] [PubMed] [Google Scholar]
  25. Tilg H, Adolph TE, Trauner M. 2022. Gut-liver axis: pathophysiological concepts and clinical implications. Cell Metabolism, 34(11), 1700–1718. [CrossRef] [PubMed] [Google Scholar]
  26. Wei X, Yan X, Zou D, Yang Z, Wang X, Liu W, Wang S, Li X, Han J, Huang L, Yuan J. 2013. Abnormal fecal microbiota community and functions in patients with hepatitis B liver cirrhosis as revealed by a metagenomic approach. BMC Gastroenterology, 13, 175. [CrossRef] [PubMed] [Google Scholar]
  27. Woodhouse CA, Patel VC, Singanayagam A, Shawcross DL. 2018. Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease. Alimentary Pharmacology & Therapeutics, 47(2), 192–202. [CrossRef] [PubMed] [Google Scholar]
  28. Wu T, Bowman DD. 2020. Visceral larval migrans of Toxocara canis and Toxocara cati in non-canid and non-felid hosts. Advances in Parasitology, 109, 63–88. [CrossRef] [PubMed] [Google Scholar]
  29. Yang L, Dai Y, He H, Liu Z, Liao S, Zhang Y, Liao G, An Z. 2022. Integrative analysis of gut microbiota and fecal metabolites in metabolic associated fatty liver disease patients. Frontiers in Microbiology, 13, 969757. [CrossRef] [PubMed] [Google Scholar]
  30. Yang XA, Lv F, Wang R, Chang Y, Zhao Y, Cui X, Li H, Yang S, Li S, Zhao X????, Mo Z, Yang F. 2020. Potential role of intestinal microflora in disease progression among patients with different stages of hepatitis B. Gut Pathogens, 12, 50. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.